DELIVERY ORDER
Active75N93026F00003
Department of Health and Human Services › National Institutes of Health › NATIONAL INSTITUTES OF HEALTH NIAID
$545.5K
obligated · signed 6 days ago
THERAPEUTIC TESTING IN MURINE MODELS OF BACTERIAL INFECTION
Performance timeline
Start
Sep 30, 2026
End
Sep 29, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Sep 29, 2027
PHARMACOLOGY DISCOVERY SERVICES TAIWAN, LTD.
Contract 75N93026F00003
UEI
MXP1NVQ8C1J8
Parent Company
PHARMACOLOGY DISCOVERY SERVICES TAIWAN, LTD.
Capabilities & Certifications
Headquarters Location
Current Obligation
$545,542
Base + Exercised Options
$545,542
Total Ceiling Value
$2,309,947
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Awarding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NIAID
Office
Funding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NIAID
Office
Contract Vehicle
75N93024D00017
IDCDepartment of Health and Human Services
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.